Ionis Pharmaceuticals’ Director, Michael R. Hayden, purchased 20,000 shares of IONS on Friday for a total of $1.06 million, at $52.94 per share. This marks his first insider buy in the past year. As of Monday, Ionis Pharmaceuticals is trading up approximately 2.4%.
Additionally, VFC’s President and CEO, Bracken Darrell, bought 32,894 shares for $14.98 each, totaling around $492,752 on the same day. VFC’s stock is up about 5.2% on Monday.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
